Aprea Therapeutics, Inc. — 10-Q Filings
19 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 19 10-Q documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001104659-25-109867 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001558370-25-011152 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001558370-25-007667 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001558370-24-014767 | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001558370-24-011806 | Aug 12, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001558370-24-008069 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001558370-23-018572 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001558370-23-014405 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001558370-23-009887 | May 15, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001558370-22-017205 | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001558370-22-013512 | Aug 12, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001558370-22-008955 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001558370-21-015053 | Nov 8, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001558370-21-011504 | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001558370-21-006263 | May 6, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001558370-20-013179 | Nov 6, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001558370-20-010336 | Aug 11, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001558370-20-006741 | May 15, 2020 | Mar 31, 2020 |
| 10-Q | 10-Q | 0001104659-19-064239 | Nov 14, 2019 | Sep 30, 2019 |